Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3795_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
09.09.2026
Размер:
18 Мб
Скачать
Epidemiology and Clinical Approach to Aortic Valve Disease
27
Complimentary Contributor Copy
https://t.me/med1917
Diagnosis and Evaluation
Echocardiography allows to diagnose acute AR, assess its severity, and in some cases to identify the underlying cause (such as infective endocarditis or aortic dissection). Color Doppler echocardiography demonstrates the backflow of blood across the aortic valve in diastole. The regurgitant jet is either central or eccentric, and the vena contracta width might be >6 mm. Holodiastolic flow reversal can be observed in the descending thoracic and proximal abdominal aorta [5]. In very severe cases, the late diastolic velocity approaches zero, indicating that aortic diastolic pressure and LV diastolic pressure are virtually identical [53, 54]. Signs of rapid pressure equalization of diastolic aortic and LV pressures include a dense continuous wave Doppler signal with a steep diastolic slope (pressure half-time <200 ms), and a short mitral deceleration time (<150 ms) and premature closure of the mitral valve. Importantly, the criteria for severe chronic AR may underestimate the severity of acute AR [55]. Echocardiography also enables evaluation of LV size and systolic function (which are often normal), and may provide information on the cause of valve dysfunction, by showing for example aortic dilatation and dissection or the presence of valvular vegetations. TEE is useful for identifying the mechanism of acute AR in the setting of aortic dissection, which may affect decision-making about the surgical procedure [56]. ECG changes are nonspecific. ST and T wave abnormalities are common, and patients may develop a myocardial infarction because of coronary occlusion in the setting of aortic dissection. Chest radiograph may show evidence of pulmonary edema, an enlarged cardiac silhouette because of pericardial effusion, or aortic root dilation [5]. When aortic dissection is suspected, TEE or CT can be performed, with high and similar values of sensitivity and specificity. CT imaging may help identify the intimal flap, the site and extent of dissection and the possible involvement of major branch arteries. Emergency valve surgery should not be delayed for coronary angiography if there is severe acute AR with hemodynamic instability. If the patient is reasonably stable, coronary angiography is generally performed in patients with CAD [18]. Aortography is indicated only when the diagnosis cannot be established by noninvasive imaging [5].
Chronic Aortic Regurgitation
Symptoms
Patients with chronic AR may remain asymptomatic for decades, even if there is progressive LV dilation. Symptoms that develop in some patients with severe AR include exertional dyspnea, angina, and other symptoms of HF. Dyspnea on effort and other HF symptoms (such as orthopnea or paroxysmal nocturnal dyspnea) are usually associated with LV systolic dysfunction. Angina during exercise can occur in the absence of significant CAD and is caused by reduced coronary flow reserve, as epicardial coronary flow shifts from predominantly diastolic to predominantly systolic. Angina can also occur at night when the heart rate slows, arterial diastolic pressure falls, and regurgitant volume increases, thus reducing coronary diastolic perfusion pressure. Some patients with severe AR may complain of symptoms related to the increased LV size and stroke volume. These include an uncomfortable awareness of the heartbeat, and atypical chest pain. These symptoms are especially pronounced when lying down or lying on the left side, which brings the LV apex closer to the chest wall.
Claudio Passino, Valentina Galfo, Simone Gasparini et al.
28
Complimentary Contributor Copy
https://t.me/med1917
Signs
The physical examination in patients with chronic severe AR provides many clues to the diagnosis, though findings are frequently more subtle in patients with milder disease. A variety of signs are caused by the wide pulse pressure in patients with chronic AR (Table 3). Among the four signs with sufficient literature for review (Corrigan pulse, Duroziez sign, Hill sign, and Austin Flint murmur), the Hill sign had a 75-100% sensitivity and a 71-100% specificity [57]. On precordial inspection and palpation, the apical impulse is displaced laterally and inferiorly and becomes diffuse and hyperdynamic. A prominent pulsation (and occasionally a thrill) may be felt at the sternal notch due to concurrent dilation of the ascending aorta. A diastolic murmur is a key sign favoring the diagnosis of AR, although the absence of a diastolic murmur does not exclude the diagnosis. The presence of an early diastolic murmur, as heard by a cardiologist, was the most useful finding for establishing the presence of AR (positive likelihood ratio 8.8) and its absence the most useful finding for reducing the likelihood of AR (negative likelihood ratio 0.2-0.3) [58]. On the other hand, widely different frequencies of a diastolic murmur among patients with chronic AR have been reported (14 to 73%) [59]. The diastolic murmur of AR begins immediately after A2. It has a high pitch, often blowing quality, and may be sustained or having a decreasing intensity. It may be soft and barely audible, often appreciated only when the patient is sitting up, leaning forward, and holding his or her breath in end-expiration. The intensity of the diastolic murmur does not correlate well with the severity of AR. The timing and duration of the murmur may be helpful in assessing the severity of AR:
In mild AR, the murmur occurs only in early diastole and is blowing.
As the regurgitation becomes more severe, the murmur extends through more of
diastole, may become holodiastolic, and is often rougher in quality. Patients with a longer diastolic murmur, a displaced LV impulse, a wide pulse pressure, and the peripheral findings of a wide pulse pressure cited in the previous section are considered to have severe AR.
In very severe regurgitation with ventricular decompensation, the murmur may
become soft or even absent. This change in character reflects the near equalization of aortic diastolic and LV diastolic pressures, which diminish regurgitant flow. A similar situation can occur when AR is acute and the LV diastolic pressure is very high. The intensity of the murmur can also be affected by certain maneuvers. For example, the intensity of the murmur increases with squatting and decreases with the Valsalva maneuver. The site at which the murmur is best heard varies with the cause. The murmur is heard best along the left sternal border, at the third and fourth intercostal space, when AR is due to valvular disease. In contrast, abnormalities of the aortic root produce murmurs that are best heard at the right sternal border and apex. A mid-systolic murmur is heard in many patients with AR [59, 60]. The systolic murmur typically resembles the ejection type of murmur heard in aortic stenosis, i.e., a crescendo-decrescendo harsh murmur beginning after S1. This murmur is caused by a large ejection volume and thus does not necessarily reflect concurrent AS. A second type of diastolic murmur (the Austin Flint murmur) may also be appreciated. This murmur is a low-pitched, mid-to-late diastolic rumble, best heard at the apex. The murmur has been attributed to the effects of competing antegrade turbulent diastolic blood flow from the left atrium and the retrograde
Epidemiology and Clinical Approach to Aortic Valve Disease
29
Sign
Manifestations
Corrigan pulse
“Water hammer” or “collapsing” pulse (rapidly rising and falling arterial pulse
with a wide pulse pressure). Best appreciated in correspondence of radial, brachial, and carotid arteries.
de Mussets sign
Head bob in correspondence of each heartbeat.
Traubes sign
“Pistol shot” pulse (systolic and diastolic sounds) in correspondence of femoral arteries.
Duroziezs sign
Systolic and diastolic bruit heard when the femoral artery is partially compressed.
Quinckes pulses
Capillary pulsations in the fingertips or lips.
Muellers sign
Systolic pulsations of the uvula.
Beckers sign
Visible pulsation of the retinal arteries.
Landolfis sign
Constriction and dilation of the pupils with each heartbeat.
Hills sign
Popliteal cuff systolic pressure exceeding brachial cuff pressure by more than 20 mmHg with patient in the recumbent position.
Maynes sign
>15 mmHg decrease in diastolic blood pressure with arm elevation from the value obtained with the arm in the standard position.
Rosenbachs sign
Systolic pulsations of the liver.
Gerhards sign
Systolic pulsations of the spleen.
Complimentary Contributor Copy
https://t.me/med1917
regurgitant flow from the aorta. The sensitivity and specificity of the Austin Flint murmur is uncertain. A review found a higher sensitivity (57 to 100%) among patients with severe AR compared with patients with mild to moderate disease (0 to 50%) [57]. The heart sounds typically have the following characteristics: S1 may be soft, often reflecting a long PR interval; S2 is variable; it may be soft, absent, or single; A2 is often soft or absent while P2 may be normal, but obscured by the diastolic murmur; a systolic ejection sound may be due to abrupt aortic distension caused by the large stroke volume; a third heart sound (S3 gallop) is heard when LV function is severely depressed.
Table 3. Signs of aortic regurgitation
Adapted from: Babu et al., 2003 [57].
Diagnosis and Evaluation
Chronic AR should be suspected in patients with physical examination findings consistent with AR, as symptoms develop only in a late disease stage. In addition, AR should be suspected in patients with dilated aortic sinuses or ascending aorta and in patients with bicuspid aortic valve, even if no murmur is apparent [18]. A TTE examination confirms the diagnosis of AR, establishes its severity, provides an assessment of aortic root and ascending aorta dilation, and evaluates LV size and function. Characteristic echocardiographic findings include the following:
valve leaflets may be abnormal or may be normal but stretched due to aortic dilation,
depending on the etiology of the AR. Abnormalities that may be seen include thickening, vegetations, calcification, a bicuspid valve, and prolapsed or flail leaflets;
the aortic sinuses are often dilated with or without dilation of the ascending aorta. A
thoracic aortic aneurysm is defined as an aortic diameter is ≥50% greater than the expected normal diameter but many patients have valve dysfunction due to aortic enlargement with a smaller degree of dilation;
Claudio Passino, Valentina Galfo, Simone Gasparini et al.
30
Qualitative
Semiquantitative
Quantitative
Valve morphology: abnormal/flail/large coaptation defect
Vena contracta width:
>6 mm
EROA:
≥30 mm2
Color flow regurgitant jet: large in central jets, variable in eccentric jets
Pressure half-time:
<200 ms
Regurgitant volume: ≥60 mL/beat
CW signal of regurgitant jet: dense
Increased LV volume
Holodiatolic flow reversal in descending aorta:
EDV >20 cm/s
Complimentary Contributor Copy
https://t.me/med1917
there is often restriction of opening of the anterior mitral leaflet and M-mode
showing high frequency diastolic fluttering, which are due to the diastolic regurgitant jet of blood from the aorta;
Doppler echocardiography (transthoracic or transesophageal) is the most sensitive
noninvasive technique for detecting the regurgitant AR jet;
the LV end-systolic and end-diastolic dimensions and volumes are increased in
chronic AR. Wall motion is increased in parallel with the large stroke volume, but the ejection fraction does not increase. When LV decompensation occurs, the ejection fraction declines and end-systolic dimension and volume increases. Together with clinical evaluation of patient symptoms, echocardiography helps define the disease stage according to valve anatomy, severity of AR, and LV size and function, which in turn determines the need for AVR. The European Society of Cardiology guidelines have proposed qualitative, semiquantitative and quantitative criteria to define chronic AR as severe (Table 4). An ECG is not indicated for diagnosis of AR but is commonly included in the evaluation of patients with AR. ECG findings may reflect the adaptive changes that occur in the LV as a result of the volume overload, and typically shows evidence of LV eccentric hypertrophy. Conduction abnormalities are usually not seen, but can occur late in the course of AR when significant LV dysfunction occurs. Isolated atrial and ventricular premature beats are common, but sustained supraventricular or ventricular tachyarrhythmias are unusual in the absence of significant LV dysfunction. A chest radiograph may be obtained in selected patients with AR such as those in whom the cause of dyspnea is uncertain. In patients with severe AR, chest radiograph shows cardiac enlargement in an inferior and leftward direction. The ascending aorta (and often the aortic arch or knob) are often dilated. Left atrial enlargement does not occur unless there is significant LV dysfunction. In patients with a suboptimal or inconclusive TTE, CMR imaging is indicated to quantify AR severity, measure LV diastolic and systolic volumes, and assess LV systolic function [18]. Aortic regurgitant volume and regurgitant orifice area can be quantified. Aortic root angiography and cardiac catheterization with measurement of LV pressures are indicated when noninvasive tests are inconclusive or provide discrepant results from clinical findings [18].
Table 4. Features of severe aortic regurgitation
CW, Continuous-wave; EROA, effective regurgitant orifice area; EDV, end-diastolic volume; LV, left ventricle.
Staging and Serial Monitoring
A staging system considering valve anatomy and hemodynamics as well as symptoms has been proposed (Table 2) [18]. The frequency of serial clinical and echocardiographic
Epidemiology and Clinical Approach to Aortic Valve Disease
31
Complimentary Contributor Copy
https://t.me/med1917
monitoring in patients with asymptomatic aortic regurgitation varies with the severity of the disease, LV dimensions and LVEF, and the rate of disease progression on previous examinations.
CONCLUSION
Aortic valve disease is an important cause of morbidity in both industrialized and developing countries, although the etiology is profoundly different in the two settings. A careful search for signs and symptoms may provide the first clues to the presence of aortic valve disease, which can then be verified and characterized by imaging techniques, starting from TTE. In patients with known severe aortic valve disease, prompt detection of symptom onset is crucial to refer them to AVR or TAVI (in the case of AS), or AVR (in AR). Furthermore, a correct interpretation of the signs and symptoms of acute AR can result in a rapid diagnostic workup and prompt patient referral to surgery.
REFERENCES
[1] Braunwald, E. Aortic Stenosis: Then and Now. Circulation., 2018, 137(20), 2099-100. [2] Joseph, J; Naqvi, SY; Giri, J; Goldberg, S. Aortic Stenosis: Pathophysiology,
Diagnosis, and Therapy. The American journal of medicine., 2017, 130(3), 253-63.
[3] Eveborn, GW; Schirmer, H; Heggelund, G; Lunde, P; Rasmussen, K. The evolving
epidemiology of valvular aortic stenosis. the Tromso study. Heart (British Cardiac Society)., 2013, 99(6), 396-400.
[4] Roberts, WC; Ko, JM. Frequency by decades of unicuspid, bicuspid, and tricuspid
aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation., 2005, 111(7), 920-5.
[5] Flint, N; Wunderlich, NC; Shmueli, H; Ben-Zekry, S; Siegel, RJ; Beigel, R. Aortic
Regurgitation. Current cardiology reports., 2019, 21(7), 65.
[6] Akinseye, OA; Pathak, A; Ibebuogu, UN. Aortic Valve Regurgitation: A
Comprehensive Review. Current problems in cardiology., 2018, 43(8), 315-34.
[7] Blaszyk, H; Witkiewicz, AJ; Edwards, WD. Acute aortic regurgitation due to
spontaneous rupture of a fenestrated cusp: report in a 65-year-old man and review of seven additional cases. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology., 1999, 8(4), 213-6.
[8] Yang, LT; Liu, PY; Lee, CH; Kan, CD; Li, YH; Tsai, LM; et al. Acute aortic
regurgitation caused by spontaneous aortic valve rupture. The Annals of thoracic surgery., 2013, 96(6), e147-9.
[9] Mahara, K; Ota, M; Kishiki, K; Takanashi, S. Acute Aortic Valve Regurgitation Due to
Spontaneous Rupture of Fenestrated Cusp Treated With Aortic Valve Repair. Circulation journal: official journal of the Japanese Circulation Society., 2017, 81(2), 241-2.
[10] Pretre, R; Faidutti, B. Surgical management of aortic valve injury after nonpenetrating
trauma. The Annals of thoracic surgery., 1993, 56(6), 1426-31.
Claudio Passino, Valentina Galfo, Simone Gasparini et al.
32
Complimentary Contributor Copy
https://t.me/med1917
[11] Onorati, F; De Santo, LS; Carozza, A; De Feo, M; Renzulli, A; Cotrufo, M. Marfan
syndrome as a predisposing factor for traumatic aortic insufficiency. The Annals of thoracic surgery., 2004, 77(6), 2192-4.
[12] Isner, JM. Acute catastrophic complications of balloon aortic valvuloplasty. The
Mansfield Scientific Aortic Valvuloplasty Registry Investigators. Journal of the American College of Cardiology., 1991, 17(6), 1436-44.
[13] Dall’Ara, G; Saia, F; Moretti, C; Marrozzini, C; Taglieri, N; Bordoni, B; et al.
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions., 2017, 89(4), E145-e52.
[14] Roberts, WC; Ko, JM; Moore, TR; Jones, WH. 3rd. Causes of pure aortic regurgitation
in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation., 2006, 114(5), 422-9.
[15] Stout, KK; Verrier, ED. Acute valvular regurgitation. Circulation., 2009, 119(25),
3232-41.
[16] Singh, JP; Evans, JC; Levy, D; Larson, MG; Freed, LA; Fuller, DL; et al. Prevalence
and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). The American journal of cardiology., 1999, 83(6), 897-902.
[17] Otto, CM; Prendergast B. Aortic-valve stenosis--from patients at risk to severe valve
obstruction. The New England journal of medicine., 2014, 371(8), 744-56.
[18] Nishimura, RA; Otto, CM; Bonow, RO; Carabello, BA; Erwin, JP; 3rd. Guyton, RA; et
al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology., 2014, 63(22), 2438-88.
[19] Park, SJ; Enriquez-Sarano, M; Chang, SA; Choi, JO; Lee, SC; Park, SW; et al.
Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC Cardiovascular imaging., 2013, 6(2), 137-46.
[20] Silaruks, S; Clark, D; Thinkhamrop, B; Sia, B; Buxton, B; Tonkin, A. Angina pectoris
and coronary artery disease in severe isolated valvular aortic stenosis. Heart, lung & circulation., 2001, 10(1), 14-23.
[21] Tansuphaswadikul, S; Silaruks, S; Lehmongkol, R; Chakorn, T. Frequency of angina
pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet., 1999, 82(2), 140-9.
[22] Green, SJ; Pizzarello, RA; Padmanabhan, VT; Ong, LY; Hall, MH; Tortolani, AJ.
Relation of angina pectoris to coronary artery disease in aortic valve stenosis. The American journal of cardiology., 1985, 55(8), 1063-5.
[23] Julius, BK; Spillmann, M; Vassalli, G; Villari, B; Eberli, FR; Hess, OM. Angina
pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation., 1997, 95(4), 892-8.
[24] Munt, B; Legget, ME; Kraft, CD; Miyake-Hull, CY; Fujioka, M; Otto, CM. Physical
examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. American heart journal., 1999, 137(2), 298-306.
[25] Etchells, E; Bell, C; Robb, K. Does this patient have an abnormal systolic murmur?
Jama., 1997, 277(7), 564-71.
Epidemiology and Clinical Approach to Aortic Valve Disease
33
Complimentary Contributor Copy
https://t.me/med1917
[26] Etchells, E; Glenns, V; Shadowitz, S; Bell, C; Siu, S. A bedside clinical prediction rule
for detecting moderate or severe aortic stenosis. Journal of general internal medicine., 1998, 13(10), 699-704.
[27] Otto, CM. Aortic stenosis. Clinical evaluation and optimal timing of surgery.
Cardiology clinics., 1998, 16(3), 353-73, vii.
[28] Baumgartner, HC; Hung, JCC; Bermejo, J; Chambers, JB; Edvardsen, T; Goldstein, S;
et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. European heart journal cardiovascular Imaging., 2017, 18(3), 254-75.
[29] Gerber, IL; Stewart, RA; Legget, ME; West, TM; French, RL; Sutton, TM; et al.
Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation., 2003, 107(14), 1884-90.
[30] Lim, P; Monin, JL; Monchi, M; Garot, J; Pasquet, A; Hittinger, L; et al. Predictors of
outcome in patients with severe aortic stenosis and normal LV function: role of B-type natriuretic peptide. European heart journal., 2004, 25(22), 2048-53.
[31] Weber, M; Arnold, R; Rau, M; Elsaesser, A; Brandt, R; Mitrovic, V; et al. Relation of
N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. European heart journal., 2005, 26(10), 1023-30.
[32] Bergler-Klein, J; Klaar, U; Heger, M; Rosenhek, R; Mundigler, G; Gabriel, H; et al.
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation., 2004, 109(19), 2302-8.
[33] Clavel, MA; Malouf, J; Michelena, HI; Suri, RM; Jaffe, AS; Mahoney, DW; et al. B-
type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. Journal of the American College of Cardiology., 2014, 63(19), 2016-25.
[34] Baumgartner, H; Falk, V; Bax, JJ; De Bonis, M; Hamm, C; Holm, PJ; et al. 2017
ESC/EACTS Guidelines for the management of valvular heart disease. European heart journal., 2017, 38(36), 2739-91.
[35] Clavel, MA; Messika-Zeitoun, D; Pibarot, P; Aggarwal, SR; Malouf, J; Araoz, PA; et
al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. Journal of the American College of Cardiology., 2013, 62(24), 2329-38.
[36] Clavel, MA; Pibarot, P; Messika-Zeitoun, D; Capoulade, R; Malouf, J; Aggarval, S; et
al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. Journal of the American College of Cardiology., 2014, 64(12), 1202-13.
[37] John, AS; Dill, T; Brandt, RR; Rau, M; Ricken, W; Bachmann, G; et al. Magnetic
resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? Journal of the American College of Cardiology., 2003, 42(3), 519-26.
[38] Friedrich, MG; Schulz-Menger, J; Poetsch, T; Pilz, B; Uhlich, F; Dietz, R.
Quantification of valvular aortic stenosis by magnetic resonance imaging. American heart journal., 2002, 144(2), 329-34.
[39] Kilner, PJ; Manzara, CC; Mohiaddin, RH; Pennell, DJ; Sutton, MG; Firmin, DN; et al.
Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis.
Circulation., 1993, 87(4), 1239-48.
Claudio Passino, Valentina Galfo, Simone Gasparini et al.
34
Complimentary Contributor Copy
https://t.me/med1917
[40] Faggiano, P; Antonini-Canterin, F; Ribichini, F; D’Aloia A; Ferrero, V; Cervesato, E;
et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. The American journal of cardiology., 2000, 85(2), 204-8.
[41] Sorgato, A; Faggiano, P; Aurigemma, GP; Rusconi, C; Gaasch, WH. Ventricular
arrhythmias in adult aortic stenosis: prevalence, mechanisms, and clinical relevance. Chest., 1998, 113(2), 482-91.
[42] Bang, CN; Greve, AM; Boman, K; Egstrup, K; Gohlke-Baerwolf, C; Kober, L; et al.
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. American heart journal., 2012, 163(4), 690-6.
[43] Greve, AM; Gerdts, E; Boman, K; Gohlke-Baerwolf, C; Rossebo, AB; Nienaber, CA;
et al. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. International journal of cardiology., 2013, 166(1), 72-6.
[44] Stortecky, S; Buellesfeld, L; Wenaweser, P; Heg, D; Pilgrim, T; Khattab, AA; et al.
Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circulation Cardiovascular interventions., 2013, 6(1), 77-84.
[45] Tarantini, G; Mojoli, M; Urena, M; Vahanian, A. Atrial fibrillation in patients
undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. European heart journal., 2017, 38(17), 1285-93.
[46] Gersony, WM; Hayes, CJ; Driscoll, DJ; Keane, JF; Kidd, L; O’Fallon, WM; et al.
Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation., 1993, 87(2 Suppl), I121-6.
[47] Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; et al. Acquired
von Willebrand syndrome in aortic stenosis. The New England journal of medicine., 2003, 349(4), 343-9.
[48] Hudzik, B; Wilczek, K; Gasior, M. Heyde syndrome: gastrointestinal bleeding and
aortic stenosis. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne., 2016, 188(2), 135-8.
[49] Pareti, FI; Lattuada, A; Bressi, C; Zanobini, M; Sala, A; Steffan, A; et al. Proteolysis of
von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation., 2000, 102(11), 1290-5.
[50] Natorska, J; Bykowska, K; Hlawaty, M; Marek, G; Sadowski, J; Undas, A. Increased
thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to­severe aortic stenosis. Heart (British Cardiac Society)., 2011, 97(24), 2023-8.
[51] Blackshear, JL; Wysokinska, EM; Safford, RE; Thomas, CS; Stark, ME; Shapiro, BP;
et al. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). The American journal of cardiology., 2013, 111(3), 374-81.
[52] Pretre, R; Von Segesser, LK. Aortic dissection. Lancet (London, England)., 1997,
349(9063), 1461-4.
[53] Grande, RD; Katz, WE. Acute aortic regurgitation secondary to disk embolization of a
Bjork-Shiley prosthetic aortic valve. Journal of the American Society of
Epidemiology and Clinical Approach to Aortic Valve Disease
35
Complimentary Contributor Copy
https://t.me/med1917
Echocardiography: official publication of the American Society of Echocardiography., 2011, 24(3), 350.e5-6.
[54] Saranteas, T; Christodoulaki, K; Rinaki, D; Kostopanagiotou, G. Transthoracic
echocardiography for the identification of acute aortic regurgitation in the intensive care unit. Journal of cardiothoracic and vascular anesthesia., 2011, 25(1), 204-5.
[55] Zoghbi, WA; Enriquez-Sarano, M; Foster, E; Grayburn, PA; Kraft, CD; Levine, RA; et
al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography., 2003, 16(7), 777-802.
[56] Patel, PA; Bavaria, JE; Ghadimi, K; Gutsche, JT; Vallabhajosyula, P; Ko, HA; et al.
Aortic Regurgitation in Acute Type-A Aortic Dissection: A Clinical Classification for the Perioperative Echocardiographer in the Era of the Functional Aortic Annulus. Journal of cardiothoracic and vascular anesthesia., 2018, 32(1), 586-97.
[57] Babu, AN; Kymes, SM; Carpenter Fryer, SM. Eponyms and the diagnosis of aortic
regurgitation, what says the evidence? Annals of internal medicine., 2003, 138(9), 736-
42.
[58] Choudhry, NK; Etchells, EE. The rational clinical examination. Does this patient have
aortic regurgitation? Jama., 1999, 281(23), 2231-8.
[59] Heidenreich, PA; Schnittger, I; Hancock, SL; Atwood, JE. A systolic murmur is a
common presentation of aortic regurgitation detected by echocardiography. Clinical cardiology., 2004, 27(9), 502-6.
[60] Attenhofer Jost, CH; Turina, J; Mayer, K; Seifert, B; Amann, FW; Buechi, M; et al.
Echocardiography in the evaluation of systolic murmurs of unknown cause. The American journal of medicine., 2000, 108(8), 614-20.
Complimentary Contributor Copy
https://t.me/med1917